| 中文名称 | 咪喹莫特 |
|---|---|
| 中文别名 | 咪喹莫特;1-(2-甲基丙基)-4-氨基-1H-咪唑并[4,5-c]喹啉;1-异丁基-1H-咪唑[4.5-C]喹啉-4-胺基;1-异丁基-4-氨基-1H-咪唑并[4,5-C]喹啉;Imiquimod 咪喹莫特;反-N-苄氧羰基-4-羟基-L-脯氨酸;咪喹莫特(imiquimod)杂质对照品;咪喹莫特-D9;咪喹莫特标准品;抗尖锐湿疣、免疫调节剂;咪喹莫特(对照品) |
| 英文名称 | Imiquimod |
| 英文别名 | Imiquimod;R-837;S-26308;1-(2-METHYLPROPYL)-1H-IMIDAZO[4,5-C]QUINOLIN-4-AMINE;4-amino- 1-isobutyl-1h-imidazo[4,5-c]quinoline;ALDARA;1-isoButyl-1H-Inudazole[4.5-c]quinoline-4-amine;1-(2-Methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine, R-837, S-26308, Aldara;Imiquimod (R837, S-26308,Zyclara®, Aldara®, Beselna®);R 837;1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine;1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine;4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline;Zyclara;Beselna;4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline;1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine;Imiquimod acetate;S 26308;C14H16N4;1-isobutylimidazo[4,5-c]quinolin-4-amine;P1QW714R7M;1H-Imidazo[4,5-c]quinolin-4;FT-0602727;KS-5218;NCGC00070736-03;BRD-K26657438-001-01-2;CHEBI:36704;TMX 101;MTD-39;1H-Imidazo[4, 1-(2-methylpropyl)-;1-(2-methylpropyl)-1Himidazo[4,5-c]quinolin-4-amine;D02500;SR-01000611320-2;NCGC00070736-02;Cellulose, hydrogen 1,2-benzenedicarboxylate, 2-hydroxypropyl methyl ether;SCHEMBL26136;Zartra;CCG-208015;NSC759651;S26308;DTXCID5021047;CAS-99011-02-6;IMIQUIMOD [WHO-DD];NSC 759651;NSC741062;NCGC00070736-04;IMIQUIMOD [EMA EPAR];MLS000083577;s1211;1-isobutyl-1H-imidazo[4,5-c]quinoline-4-amine;AB00399298-06;9050-31-1;AKOS005507352;(Hydroxypropyl)methyl cellulose phthalate;UNII-P1QW714R7M;IMIQUIMOD [VANDF];Imiquimod, >=98% (HPLC), solid;IMIQUIMOD [USP-RS];SY017571;1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-ylamine;99011-02-6;Zyclara (TN);Imiquimod (JAN/USP/INN);Q423417;IMIQUIMOD [USAN];NSC-811538;I0747;NSC 369100;IMIQUIMOD [MI];HSDB 8129;IMIQUIMOD (USP-RS);1-isobutyl-1H-imidazo [4,5-c]quinolin-4-amine;BDBM50240849;1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-;IMIQUIMOD [JAN];BI164576;BRD-K26657438-001-13-7;IMIQUIMOD [ORANGE BOOK];HB3109;HMS2090M14;SMR000048307;AB00399298-07;AB00399298_09;1-isobutyl-1H-imidazo(4,5-c)quinolin-4-amine;Imiquimodum;HY-B0180;Imiquimod,(S);Z2588038940;IMIQUIMOD (MART.);SR-01000611320-3;IMIQUIMOD (USP MONOGRAPH);IMIQUIMOD [USP MONOGRAPH];NSC-759651;BCP05151;Imiquimod 100 microg/mL in Acetonitrile;D06BB10;HMS3715N19;SR-01000611320;AC-529;1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-;AB00399298-05;CHEMBL1282;6T0;BIDD:GT0859;DZ-2636;EN300-6477856;Tox21_110985;NSC 741062;IMIQUIMOD [MART.];YH44175;TMX-101;Aldara (TN);A845945;1-(2-methylpropyl)-1H-imidazo[4,5-c]-quinolin-4-amine;DB00724;HMS3747A13;1-(2-methylpropyl)-1H-imidazo(4,5-c)quinolin-4-amine;Imiquimod [USAN:INN:BAN];MFCD00866946;HMS2232G07;NSC811538;Vyloma;4-Amino-1-(2-methylpropyl)-1H-imidazo(4,5-c)quinoline;Pharmakon1600-01502351;Tox21_110985_1;NS00006714;GTPL5003;NSC369100;NSC-369100;HMS3373B13;DOUYETYNHWVLEO-UHFFFAOYSA-N;Imiquimod - CAS 99011-02-6;Imiquimod- Bio-X;Imiquimod, United States Pharmacopeia (USP) Reference Standard;IMIQUIMOD [INN];1-(2-methylpropyl)-4-imidazo[4,5-c]quinolinamine;CS-2058;R837;AB00399298_08;DTXSID7041047;BRD-K26657438-003-01-8;... |
| CAS No. | 99011-02-6 |
| 分子式 | C14H16N4 |
| 分子量 | 240.30 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学